Skip to Content

New Drug Approvals Archive - August 2010

See also: New Indications and Dosage Forms for August 2010

August 2010

Suprep (sodium sulfate, potassium sulfate, magnesium sulfate) Oral Solution

Date of Approval: August 5, 2010
Company: Braintree Laboratories, Inc.
Treatment for: Bowel Preparation

Suprep (sodium sulfate, potassium sulfate, magnesium sulfate) is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults.

ella (ulipristal acetate)

Date of Approval: August 13, 2010
Company: HRA Pharma
Treatment for: Postcoital Contraception

ella is a progesterone agonist/antagonist emergency contraceptive indicated for prevention of pregnancy following unprotected intercourse or a known or suspected contraceptive failure.

Tekamlo (aliskiren and amlodipine) Tablets

Date of Approval: August 26, 2010
Company: Novartis Pharmaceuticals Corporation
Treatment for: Hypertension

Marketing Status: Discontinued

Tekamlo (aliskiren and amlodipine) is a direct renin inhibitor and calcium channel blocker combination indicated for the treatment of high blood pressure.

New Drug Approvals Archive

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.